Diagnostic Approach to Low TSH Values

Initial Evaluation and Confirmation

The American College of Physicians recommends repeat TSH with free T4 measurement within 3-6 weeks to confirm the finding and determine if this represents subclinical or overt hyperthyroidism, as a single low TSH value requires confirmation before initiating treatment 1, 2
Do not make treatment decisions based on a single TSH value, as 30-60% of abnormal TSH levels normalize spontaneously on repeat testing 2
Measure both TSH and free T4 simultaneously on repeat testing to distinguish between subclinical hyperthyroidism (low TSH with normal free T4) and overt hyperthyroidism (low TSH with elevated free T4) 3

For patients with TSH 0.1-0.45 mIU/L and normal free T4, monitor without immediate treatment, as this range is unlikely to progress to overt hyperthyroidism, and approximately 25% of persons with subclinical hyperthyroidism revert to euthyroid state without intervention 1
For patients with TSH <0.1 mIU/L and normal free T4, this carries significantly higher risk for progression to overt hyperthyroidism and complications, and strongly consider treatment due to increased risks of atrial fibrillation, cardiac arrhythmias, bone mineral density loss, and fractures 1, 3
For patients with TSH <0.1 mIU/L and elevated free T4, this definitively indicates overt hyperthyroidism requiring prompt treatment, and initiate beta-blockers immediately for symptomatic relief, and pursue definitive treatment with methimazole, radioactive iodine ablation therapy, or surgery 3

Review all medications, particularly levothyroxine therapy, as approximately 25% of patients on levothyroxine are unintentionally overtreated with suppressed TSH, and reduce dose by 12.5-25 mcg and recheck in 6-8 weeks if on levothyroxine for hypothyroidism 2
Rule out non-thyroidal illness, as acute illness, certain medications, and recent iodine exposure can transiently suppress TSH, and defer thyroid evaluation until recovery and recheck TSH 4-6 weeks after illness resolution 1, 2

For TSH 0.1-0.45 mIU/L, recheck every 3-12 months, and for TSH <0.1 mIU/L, more frequent monitoring (every 3-6 months) and lower threshold for treatment 2, 3
Assess for development of symptoms, such as palpitations, tremor, heat intolerance, weight loss, and anxiety, and screen for atrial fibrillation with ECG, especially in patients >60 years 3
Consider bone density assessment in postmenopausal women and elderly patients with persistent TSH <0.1 mIU/L 3